Cite
HARVARD Citation
Slomovitz, B. et al. (2020). Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer. International journal of gynecological cancer. 30 (11), pp. 1733-1737. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Slomovitz, B. et al. (2020). Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer. International journal of gynecological cancer. 30 (11), pp. 1733-1737. [Online].